1. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. Issue 2 (December 2015) Authors: Ruella, Marco; Barrett, David; Kenderian, Saad; Shestova, Olga; Hofmann, Ted; Scholler, John; Lacey, Simon; Melenhorst, Jan; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David; Hunter, Christopher; Porter, David; June, Carl; Grupp, Stephan; Gill, Saar Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗